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Abstract:  Mass  transport  of  analyte  to  surface-immobilized  affinity 
reagents  is  the  fundamental  bottleneck  for  sensitive  detection  in  solid-
support  microarrays  and  biosensors.  Analyte  depletion  in  the  volume 
adjacent to the sensor causes deviation from ideal association, significantly 
slows down reaction kinetics, and causes inhomogeneous binding across the 
sensor  surface.  In  this  paper  we  use  high-resolution  molecular 
interferometric imaging (MI2), a label-free optical interferometry technique 
for  direct  detection  of  molecular  films,  to  study  the  inhomogeneous 
distribution of intra-spot binding across 100 micron-diameter protein spots. 
By  measuring intra-spot binding  inhomogeneity, reaction  kinetics can be 
determined accurately when combined with a numerical three-dimensional 
finite  element  model.  To  ensure  homogeneous  binding  across  a  spot,  a 
critical flow rate is identified in terms of the association rate ka and the spot 
diameter.  The  binding  inhomogeneity  across  a  spot  can  be  used  to 
distinguish  high-affinity  low-concentration  specific  reactions  from  low-
affinity high-concentration non-specific binding of background proteins. 
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OCIS codes: (180.3170) Interference microscopy; (280.1415) Biological sensing and 
sensors;  (280.4788)  Optical  sensing  and  sensors;  (240.6645)  Surface  differential 
reflectance; (170.1470) Blood or tissue constituent monitoring; (170.0110) Imaging 
systems. 
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1. Introduction 
Microarrays are high-throughput analytical platforms for the detection of target molecules in a 
biological sample. In a solid-support microarray, multiple affinity reagents are printed as spots 
onto a solid substrate. When incubated against a biological sample, the surface-immobilized 
affinity  reagents  react  with  their  specific  target  analytes.  With  the  capability  of  high-
throughput  detection  of  multiple  analytes  at  low  cost  and  high  sensitivity,  microarray 
technology has great potential in system-oriented proteomics [1–4], drug discovery [5] and 
multiplexed  medical  diagnostics  [6].  Progress  on  new  detection  schemes  [7–15],  surface 
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microarray reliability. However, the capability of current protein microarray technology for 
large-scale profiling of complicated biological samples is still limited, and many technical 
challenges  remain  that  significantly  limit  the  detection  sensitivity  of  microarray 
immunoassays [21]. 
The  theoretical  detection  sensitivity  of  antibody  microarrays  can  be  predicted  by  the 
ambient-analyte theory [22], which shows that the equilibrium binding site occupancy in a 
microarray immunoassay would depend only on the analyte concentration, provided that the 
amount  of  antibody  is  small  and  the  binding  of  analyte  to  the  antibody  spots  does  not 
significantly affect the bulk concentration. Under these conditions, with picomolar affinity 
antibodies and a detection system with a signal-to-noise ratio of 1000:1, femtomolar level 
detection sensitivity could be reached, but few systems have ever reached such sensitivity 
[23], and they often rely on signal amplification. 
This discrepancy between the theoretical and experimental assay sensitivity is caused by 
mass transport limitation. The ambient-analyte theory makes the assumption that the analyte 
concentration is not significantly affected by the capture process. However, in practical assays 
antibodies are often immobilized in microspots at a high surface density, which leads to high 
capture rate of analyte. When the analyte capture rate is faster than the analyte replenishment 
rate  through  mass  transport,  the  analyte  concentration  is  depleted  locally  adjacent  to  the 
antibody spots, and the reaction deviates from the ambient-analyte condition. The depletion of 
analyte drives the reaction away from ideal association, slows down the reaction and reduces 
the amount of captured analyte, possibly by orders of magnitude, and causes inhomogeneous 
analyte binding as analyte concentration varies across the antibody microspots. Among the 
technical challenges surface-based protein microarray technology faces, the mass-transport 
limitation of target analyte from sample solution to the sensor surface may be the primary 
limitation  of  current  solid-support  microarray  immunoassays  [24].  Because  of  this,  mass-
transport-limited  reaction  kinetics  have  been  studied  extensively,  by  theoretical  [25–27], 
experimental  [24,28,29]  and  computational  [30]  approaches.  However,  all  these  previous 
studies  have  focused  on  the  average  response  over  the  sensor  surface  [31]  and  have  not 
addressed  the  analyte  binding  inhomogeneity  within  the  sensor  surface,  which  is  closely 
related to the analyte concentration gradient and is the origin of the deviations from ideal 
association. 
In  this  paper,  we  employ  the  diffraction-limited  spatial  resolution  of  molecular 
interferometric imaging [32] to study mass-transport-induced analyte binding inhomogeneity 
within  single  100  micron  diameter  protein  spots.  Binding  under  commonly  encountered 
conditions leads to pronounced binding inhomogeneity within the spots. A three-dimensional 
finite element computational model is compared with the experimental results and is used to 
explore  regions  of  the  reaction  kinetics  parameter  space  that  are  not  easily  accessible  to 
experiments. We show that, in the low concentration limit, the shapes of the mass-transport-
induced reaction inhomogeneities are independent of analyte concentration, and we present 
guidelines  to  optimize  a  microarray  immunoassay  through  the  choice  of  the  size  of  an 
antibody microspot and the sample flow rate. Finally, we propose a possible use of mass-
transport-induced  reaction  inhomogeneity  to  distinguish  high-affinity  low-concentration 
specific reactions from low-affinity high-concentration non-specific binding of background 
proteins. 
2. Molecular interferometric imaging 
2.1 Molecular films 
Molecular  interferometric  imaging  is  a  sensitive  detection  platform  for  label-free 
interferometric  detection  of  surface-immobilized  biomolecules  [32,33].  MI2  is  based  on 
normal-incidence inline common-path quadrature interferometry [34] combined with far-field 
optical imaging. An oxide layer on silicon acts as a spacer layer, and interference between 
partial reflections from the bottom of the spacer layer and immobilized biomolecules on top 
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detector  on  the  image  plane  of  the  optical  system.  The  signal  and  reference  waves  are 
produced locally and share the same optical path, making the interferometry ultra-stable. 
The interference between the reflected partial waves changes the reflection coefficient of 
the substrate when protein is present. By designing the amplitude and phase of the substrate 
reflection coefficient, the protein-induced reflectance change can be maximized. One simple 
substrate is an oxide-on-silicon two-layer substrate, with a thickness at or near the condition 
of phase-quadrature that imprints a relative phase of π/2 between the partial reflections from 
the top and bottom interface of the oxide layer [35]. The relative reflectance change caused by 
the presence of protein is given by 
  ( )
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2 is the normalized point-spread function of the  imaging system and h(x,y) is the 
protein  height  function  on  the  substrate  surface.  The  coefficient  C(λ,d)  that  gives  the 
conversion from biolayer height to intensity is [34] 
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where  np  is  the  refractive  index  of  protein,  r  is  the  reflection  coefficient  of  the  substrate 
(immersed in medium) and rp is the reflection coefficient of the medium-protein interface. A 
measured change in the relative intensity can be converted to surface protein height using this 
conversion coefficient. A background normalization procedure is used to remove the spatial 
variation in the illumination background to obtain the relative intensity changes caused by 
protein. Two images of the same sample are taken either with a time shift or spatial shift, and 
then are referenced against each other by calculating the normalized difference between the 
image  pairs  [32].  This  procedure  completely  removes  the  spatial  inhomogeneity  in  the 
illumination, and the resulting measurement of protein-induced relative intensity change is 
limited only by the shot-noise of the CCD detector. 
2.2. Experimental procedures 
In  MI2,  we  measure  the  reflectance  change  caused  by  the  surface  immobilized  protein 
molecules directly with an imaging system [33]. We use 100 mm diameter silicon wafers with 
a top oxide layer as support, and choose the thickness of the oxide layer to be 120 nm. At this 
oxide  thickness,  the  protein-induced  relative  reflectance  change  is  optimized  for  630  nm 
wavelength incident light. The reflectance change caused by protein molecules under these 
conditions is positive, making it easy to distinguish from scattering loss by particle debris. 
The oxide surface is activated with an aldehyde surface chemistry that covalently binds 
protein  molecules.  The  wafer  surface  is  partitioned  into  96  independent  wells  using 
hydrophobic ink. Protein spots are then printed into these wells by a Piezo ink-jet protein 
printer (Scienion Inc., distributed by BioDot) onto the substrate in 300 pL drops, resulting in 
about 100 micron diameter printed protein spots. The printing procedure was optimized to 
produce  uniform  protein  spots.  A  2x2  unit  cell  pattern  of  protein  spots  is  used  for  the 
experiments, in  which two target and two reference protein spots are printed on opposite 
diagonals to form a single unit cell. This format provides good rejection of systematic drifts 
and common non-specific binding to both groups of spots. For each well, 16 unit cells are 
printed, resulting in an 8x8 protein spot array. 
The optical setup of the MI2 detection system consists of a monochromic light source, a 
reflective microscope and a CCD camera. The light source we used is a 10 mW red LED 
(eLED.com) with center wavelength at 630 nm and a bandwidth of 30 nm. The LED is very 
stable  with  low  intensity  drift  over  time.  Light  is  directed  from  the  light  source  into  a 
reflective microscope (Leica DMR) and focused onto the sample by objectives with 7x, 20x or 
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imaged onto a CCD camera (QImaging 4000R) and captured to a computer. 
A flow cell is constructed by attaching an anti-reflection coated (center wave-length 630 
nm, reflectance < 0.1% at 630 nm) 18x18x0.17 mm cover slide by double-sided tape on top of 
one well on a disc. The resulting height of the flow cell is approximately 0.2 mm. Sample 
solution is driven into the flow cell from one side of the cover slide and drained from the 
opposite side, with the flow rate controlled by a syringe pump (New Era NE500). The printed 
protein spots and the surface of the disc are imaged through the cover slide and the sample 
solution by the microscope system. The images taken at different times are referenced to the 
first image by calculating the normalized difference of the two images, using 
  ( )
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in which the subscript i,j denotes the pixel number in the imaging system. The normalized 
difference removes spatial inhomogeneity in the illumination background, and the result is 
proportional  to  the  protein  height  change  during  the  incubation.  The  measurement  of  the 
protein height change is then limited by the photon shot-noise from the CCD camera [27]. 
3. Experimental results 
3.1 Flow rate dependence 
To study the effect of the flow velocity on mass-transport-limited reactions, the binding of the 
Fc region of rabbit IgG against protein A/G was studied under different flow rates. Protein 
A/G is a fusion protein that contains the IgG-binding domain from protein A and protein G, 
and specifically binds only the Fc region of IgG molecules [36,37]. Protein A/G was printed 
in the 2x2 unit cell pattern described in the previous section, with chicken IgY spots serving 
as reference. 32 protein A/G spots and 32 reference spots were printed in a single array, which 
was  then  incubated  and  measured  in  a  flow  cell.  The  sample  solution  we  used  for  this 
experiment was 200 ng/mL rabbit IgG prepared in pH 7.4 phosphate buffered saline (PBS), 
with 2  g/mL bovine serum albumin as a non-specific protein background. The sample was 
introduced into the flow cell with continuous flow at velocities ranging from 5  m/sec to 50 
 m/sec. After each incubation, rabbit IgG was eluted from the protein A/G with a pH 3.0 100 
mM glycine-HCl buffer solution. 
Binding of rabbit IgG to protein A/G through the Fc region was imaged at a rate of one 
measurement  every  40  seconds.  For  each  measurement  frame,  the  responses  from  the  32 
protein A/G spots were spatially averaged together to reduce the detection shot noise of the 
CCD. The results are shown in Fig. 1 (Media 1) as a combined movie of the average binding 
inhomogeneity profile of rabbit IgG within the 120 micron diameter protein A/G spots when 
they were incubated under four different flow conditions. The flow rates in the movie are: top-
left 5  m/sec; top-right 10  m/sec; bottom-left 20  m/sec; bottom-right 50  m/sec. The data 
in the movie were acquired and averaged over the same set of protein spots in the same flow 
cell from four consecutive experiments with different flow rates. After each incubation, the 
rabbit IgG was eluted and the printed protein A/G spots were reused for the next incubation. 
No significant loss of protein activity was observed in this process. 
From Fig. 1, binding of analyte at the leading edge of the protein spots was pronounced at 
low velocity, caused by the depletion of analyte as the sample travelled across the protein 
spot. Diffusion-enhanced binding also occurs at the sides and the trailing edge of the spots, 
which also is more apparent at low flow velocities. The width of the leading binding edge 
increases  with  increasing  flow  velocity,  producing  more  uniform  binding  across  the  spot 
under flow rates above 20  m/sec. 
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Fig. 1. (Media 1) Movie of 200 ng/mL rabbit IgG binding against protein A/G under different 
flow rates of: top-left 5  m/sec; top-right 10  m/sec; bottom-left 20  m/sec; bottom-right 50 
 m/sec. Pronounced edge binding due to mass transport is observed at low flow velocities. The 
flow direction is from the upper right to lower left. 
When the analyte binding is averaged over the entire protein spot at low flow rates, the 
deficient binding in the center of the spots leads to a large deviation from the ideal association 
process. The spot-averaged binding is shown in Fig. 2(a). At flow rates below 20  m/sec 
analyte depletion from the sample suppresses binding in the center of the spot. However, 
when only the binding at the leading edges of the protein spots are used, the protein bindings 
under different flow rates are almost identical, as shown in Fig. 2(b). This is because the 
leading edges are always exposed to the bulk concentration of analyte. 
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Fig. 2. Height increase of the protein spots at different flow rates (a) averaged over the full 
spot, large deviations occur at low flow rates; (b) from only the leading edges of the protein 
spots. 
When the spot-averaged response is fitted to the ideal association equation, the resulting ka 
can vary by more than 50%, as shown in Fig. 3. The leading edge produces much smaller 
variation, in which the resulting ka values deviate by less than 5%. Therefore, by analyzing the 
leading edge of the protein spots (or by reducing the size of the spots [15,17]), the reaction 
kinetics can be measured more precisely. 
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Fig. 3. Association rate ka from fits to ideal association for the full-spot average compared with 
signals taken only from the leading edge of the spots. 
3.2 Kinetic association rate dependence 
The pronounced leading edge caused by analyte depletion depends on the kinetic association 
rates as well as the flow rate. To study the effect of the kinetic association rate on the mass-
transport-limited reaction, three different molecular binding systems were studied that had 
different ka. These were: (a) the association of streptavidin (53 kDa) to biotin (ka = 1x10
6 
M
−1sec
−1); (b) the association of rabbit IgG (150 kDa) to protein A/G bound through the Fc 
region (ka = 1x10
5 M
−1sec
−1); and (c) non-specific association of bovine serum albumin (BSA, 
66  kDa))  to  protein  A/G  (ka  =  1x10
2  M
−1sec
−1).  The  concentration  of  rabbit  IgG  and 
streptavidin for the specific binding experiments was 1  g/mL, while the concentration of 
BSA for the non-specific binding was much higher at 200  g/mL. A 50  m/sec flow rate was 
used for all three reactions. The resulting spot binding inhomogeneity is shown in Fig. 4. The 
data shown were selected when the spots showed the largest intraspot variations. A higher 
association rate leads to a larger concentration gradient and binding inhomogeneity across a 
protein  spot. Therefore, by  measuring  the  inhomogeneity  of  the  protein  spot  profile,  it  is 
possible to separate specific association at high affinity from non-specific association at lower 
affinity. High-affinity specific associations produce steep leading edges in the direction of the 
flow and large inhomogeneity across the spot, while low-affinity non-specific binding across 
the spot is uniform. When different flow velocities are used, high-affinity associations show a 
strong dependence on flow velocity in the binding profile, while low-affinity associations do 
not depend significantly on flow velocities because the reactions at low affinity are not mass-
transport limited. 
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Fig. 4. Binding inhomogeneity in (a) 1  g/mL streptavidin binding to immobilized biotinylated 
anti-rabbit IgG, (b) 1  g/mL rabbit  IgG binding to immobilized protein A/G, and (c) 200 
 g/mL BSA binding non-specifically to protein A/G. The flow velocity for all experiments was 
50  m/sec. The mass-transport effect is more obvious in larger ka reactions because of faster 
analyte depletion. 
4. Numerical modeling 
4.1 Numerical model of mass transport limited reaction 
Molecular interferometric imaging measures the optical phase shift from surface immobilized 
biomolecules, which is converted to a surface height profile. For a binding reaction between 
an immobilized capture reagent and its target analyte in sample solution, the surface height 
increase is given by 
  max ( ) a d
dH
k C H H k H
dt
= − −    (4) 
where Hmax is the saturation protein height increase, which is proportional to surface binding 
site  density,  and  C  is  the  mass  concentration  of  the  analyte  near  the  sensor  surface.  The 
association and dissociation rate constants of the reaction are ka and kd, respectively. If the 
analyte  concentration  stays  constant  in  time,  then  the  above  equation  is  solved  for  ideal 
association, 
  ( ) max ( ) 1 exp ( )
a
d a
a d
k C
H t H k k C t
k C k
= − − +     +
   (5) 
However, in a practical assay, the binding of analytes to the surface-immobilized capture 
reagents changes the analyte concentration, which changes the reaction from ideal association. 
The mass transport of analyte then comes into effect when the concentration becomes non 
uniform, and can be described by 
 
2 C
v C D C
t
∂
= − ⋅∇ + ∇
∂
￿    (6) 
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boundary condition at the reaction surface as a result of mass conservation of the analyte is 
given in terms of the mass flux 
 
C dH
D
z dt
ρ ∂
= −
∂
   (7) 
where ρ is the mass density of the analyte layer. 
For the numerical study, the boundary condition can be introduced into the differential 
equation at the boundary through 
 
2 C H
v C D C R
t t
   
= − ⋅∇ + ∇ −
   
￿    (8) 
where  R  is  a  conversion  ratio  between  surface  height  increase  and  analyte  concentration 
change, given by 
 
C
R
H l D
ρ ρ  
= = =
   
   (9) 
in which  l is the height of the sample volume in which the analyte molecules can reach the 
sensor surface in unit time. Equation (8) contains both a mass transport term and a binding 
term and is numerically equivalent to Eq. (6) and Eq. (7). 
From Eq. (8), it is clear that if there is analyte binding, then C cannot remain uniform 
across  the  sensor  surface,  because  if C  is  a  constant,  then  / / C t R H t     = −     ,  and  the 
analyte concentration has a finite time derivative. If an assay begins from a uniform bulk 
concentration, then a concentration gradient will be established across the sensor surface until 
the mass transport rate of the analyte equals to the binding rate. Because analyte association is 
directly proportional to concentration, this concentration gradient will cause inhomogeneous 
association of the analyte across the sensor surface, which leads to deviations from the ideal 
association of Eq. (5). 
We applied a three-dimensional finite element method [38] to solve the partial differential 
equation and to simulate the reactions described by Eq. (8) over a protein spot. In the FEM 
model, the binding of analyte and mass transport were calculated separately. For each time 
step, the analyte binding height dH was calculated by a finite difference method to solve  
Eq.  (4),  and  analyte  was  removed  from  the  adjacent  sample  volume.  The  finite  element 
simulation  then  solved  for  the  analyte  concentration  C  from  Eq.  (6)  in  bulk  solution.  A 
parabolic velocity profile was used for pressure-driven flow across the flow cell, 
  ( ) 6 ( / )(1 / ) m v z v z h z h = −    (10) 
where vm is the average flow velocity and h is the height of the flow cell. Additional boundary 
conditions used for the simulations are, C = Cb at t = 0, C = Cb at the inlet port of the fluidic 
channel, and  ( ) 0 n D C ⋅ ∇ =
￿ ￿
 at all other boundaries. 
4.2 Validation of FEM simulations 
The FEM simulation was compared with experimental results for validation. Figure 5 shows 
the  comparison  of  the  simulation  with  experimental  results.  A  movie  of  the  comparison 
between experimental data and simulation is shown in Fig. 5(a) (Media 2) for the association 
of rabbit IgG against protein A/G after 2 hours of incubation. The parameters for the reaction 
were a kinetic association rate ka = 1x10
5 M
−1sec
−1, a concentration Cb = 200 ng/mL, a flow 
rate v = 5  m/sec, a saturation height Hsat = 3 nm, and a diffusion coefficient D = 40  m
2/sec, 
which  is  typical  for  IgG  molecules  [39].  The  cross  sections  of  the  protein  spot  for  the 
experimental and simulation results are shown in Fig. 5(b), which shows similar profiles. The 
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Fig. 5. Comparison of experimental and numerical simulation results. (a) (Media 2) A movie 
comparing experimental data and simulation of rabbit IgG binding against protein A/G. (b) 
Cross sections of the experimental and numerical data after 2 hour incubation. 
4.3 Binding profile shapes 
To study the effects of bulk concentration and flow velocity on the shape of the binding 
profile, Eq. (4) and Eq. (8) are combined. The concentration at the sensor surface is described 
by 
  ( )
2
max ( ) a d
C
v C D C R k C H H k H
t
∂
= − ⋅∇ + ∇ − − −
∂
￿    (11) 
At  low  concentrations,  the  height  profile  of  the  protein  binding  is  determined  by  the 
concentration gradient over the spot surface, which is dependent on both the mass transport of 
analyte and on the reaction kinetics. In Eq. (11), mass transport depends on the flow velocity 
and  the  diffusion  coefficient,  while  the  reaction  kinetics  depends  on  the  association  and 
dissociation rates, as well as the saturation height of the reaction. All of these factors affect 
the concentration gradient across the spot and the resulting spot binding profile. In particular, 
at low concentrations the condition Cbulk << RHmax holds, which leads to low binding height H, 
and the concentration C in the fluid changes much faster than the surface protein height H. 
Therefore, H can be treated as slowly varying and small compared to Hmax. In this case, a 
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when the protein spot is far from saturation, the shape of the relative concentration gradient is 
independent of the analyte concentration. 
Figure 6(a) shows the simulated surface height increase across the protein spot along the 
direction of the flow after a 1000 second incubation, normalized by the height of the leading 
edge to compensate for concentration differences. The parameters used for the simulations are 
ka = 1x10
5 M
−1sec
−1, D = 40  m
2/sec, saturation height Hmax = 3 nm, and flow velocity v = 50 
 m/sec. The bulk concentrations were varied from 10 ng/mL to 10  g/mL. Except for the 
highest concentration, in which the reaction was driven close to saturation over the incubation 
time, at lower concentrations the height changes have very similar shape after normalization, 
which  shows  that  the  underlying  mass  transport  and  binding  kinetics  are  independent  of 
concentration in the low-concentration limit. 
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Fig. 6. (a) The normalized protein binding height at different concentrations across a spot. 
Except at the highest concentration, the others have similar normalized concentration profile. 
(b) Effect of active flow on the inhomogeneous binding profile of a protein spot after 1000 
seconds incubation. 
Figure 6(b) shows the effect of flow rate on the binding profile. The concentration is set at 
1  g/mL, the ka is set at 1x10
5 M
−1sec
−1, the diffusion coefficient is set at 40  m
2/sec, the 
saturation height set at 3 nm, and the flow rate changes from 0 to 50  m/sec. The incubation 
time is set at 1000 seconds. The flow increases binding at the leading edge of the spot, and the 
width of the leading edge increases as the velocity of the flow increases. Higher association 
rates and saturation heights lead to a stronger binding term in Eq. (11), which increases the 
ratio between the center and the edge, and decreases the width of the edges. Higher diffusion 
and flow increase the mass transport term in Eq. (11), which decreases the ratio between the 
center and the edge, and increases the width of the edges. 
4.4 Effect of mass transport on the time response 
The inhomogeneous binding caused by mass-transport-limited reactions reduces the amount 
of  captured  analyte  onto  the  antibody  spots,  thus  decreasing  the  sensitivity  of  the  assay.  
Figure 7(a) shows the average protein height change as a function of time under different flow 
rates. The concentration is set at 5  g/mL, ka is set at 1x10
5 M
−1sec
−1, the diffusion coefficient 
is set at 40  m
2/sec, the saturation height is 1 nm, and the flow rate changes from 0 to 500 
 m/sec. At high flow rate, the binding is close to ideal association, while for low flow rates 
insufficient mass transport leads to slower reaction and smaller binding signal. Figure 7(a) 
also shows the signal from the leading edge of the protein spots, in which depletion of analyte 
from the sample solution still results in deviation from ideal association, but the distortion is 
smaller compared to the average signal. These curves are fitted with an ideal response curve, 
and  the  resulting  effective  ka  values  for  both  the  average  response  and  the  leading  edge 
(C) 2010 OSA 1 October 2010 / Vol. 1,  No. 3 / BIOMEDICAL OPTICS EXPRESS  993
#132716 - $15.00 USD Received 2 Aug 2010; revised 16 Sep 2010; accepted 17 Sep 2010; published 20 Sep 2010response are plotted in Fig. 7(b). The effective ka values asymptotically approach the ideal 
value at 1x10
5 M
−1sec
−1 with increasing flow velocity, while for low flow rates the binding 
process is dominated by diffusion mass transport, which leads to a much slower reaction rate. 
The effective ka approaches the ideal ka when the flow velocity exceeds a threshold value 
related to ka and to the spot size. This critical velocity is discussed in the next section. 
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Fig. 7. Binding kinetics at different flow rates for 5  g/mL. (a) The average response over a 
protein spot as a function of time (dashed curves) and at the leading edge of a protein spot as a 
function of time (solid curves). (b) Effective ka for the average responses and the leading edge 
responses. The leading edge shows less deviation from ideal association, but is still strongly 
skewed from the ideal value at low flow rates. 
5. Array performance guidelines 
5.1 Optimal spot size 
The depletion of analyte  from  solution adjacent to a protein  spot results in concentration 
gradients over the same protein spot, which leads to inhomogeneous binding and reduced 
assay response. The length scale of the concentration gradient is determined by the reaction 
kinetics and mass transport conditions, and is independent of the size of the protein spots. 
Therefore, if we use protein spots with size comparable to, or smaller than, the length scale of 
the  concentration  gradient,  then  the  entire  spot  would  be  exposed  to  nearly  the  bulk 
concentration of analyte, and mass transport limitations can be reduced. We first consider the 
case for pure diffusion mass transport (no flow). Equation (11), for H << Hmax and v = 0, 
becomes 
 
2
max a
C
D C Rk CH
t
∂
= ∇ −
∂
   (12) 
To  simplify  the  problem  for  this  set  of  conditions,  only  the  one-dimensional  case  is 
considered. After a stable concentration gradient is established, then 
 
2
max 2 0 a
d C
D Rk CH
dx
− =    (13) 
and  a  characteristic  length  scale  wD  can  be  defined  for  the  concentration  gradient.  
Equation (13) becomes 
  max 2 0 a
D
C
D Rk CH
w
− =    (14) 
Because the diffusion-enhanced edge is caused by the concentration gradient, the width of 
the edge is the same as the decay length of the concentration gradient. Therefore the width of 
the diffusion edge is 
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max
D
a
D
w
Rk H
=    (15) 
If the  size of the protein spot is comparable to (or smaller than)  wD then the analyte 
concentration over the spot would not change significantly. Conversely, from this relation, if 
the association rate and saturation height are known, the diffusion coefficient of the analyte 
can be calculated from the width of the diffusion edge. By using the definition of R in Eq. (9), 
for an immunoassay with D = 40  m
2/sec, ρ = 1.3 g/cm
3, ka = 1x10
5 M
−1sec
−1 and Hmax = 3 
nm, the calculated width of the diffusion edge is about 10  m. This matches well with the 
experimental data at low flow rates in Fig. 5, in which the pixel resolution is 2.2  m and the 
diffusion edge at the left and right of the spot parallel to the flow direction is about 4 pixels 
wide. 
When active flow is added, and still considering only the one-dimensional case, Eq. (11) 
becomes 
 
2
max 2 0 a
dC d C
v D Rk CH
dx dx
− + − =    (16) 
A characteristic length scale also can be associated with the flow term in Eq. (15), which 
then becomes 
  max 2 0 a
F D
C C
v D Rk CH
w w
+ − =    (17) 
If the contribution of the flow is larger than diffusion, the characteristic length scale of the 
concentration gradient wF is given by 
  max / F a w v Rk H ≈    (18) 
If  the  size  of  the  protein  spot  is  comparable  to  (or  smaller  than)  the  width  of  the 
concentration gradient, then the mass transport limitations can also be minimized. By using 
the  definition  of  R  in  Eq.  (9),  with  a  ka  of  1x10
5  M
−1sec
−1,  a  diffusion  coefficient  of  40 
 m
2/sec and a saturation height of 3 nm, for a 5  m/sec flow rate the width of the leading edge 
is about 12  m, and at 50  m/sec flow rate the width of the leading edge is about 120  m, 
which is the same as the size of the protein microspot This agrees with the experimental data 
in Fig. 1, in which the 5  m/sec flow rate produces a pronounced binding edge, while the 50 
 m/sec flow rate leads to uniform binding across the spot. 
Equation  (18)  can  be  used  to  estimate  the  critical  flow  velocity  needed  to  prevent 
significant  mass  transport  effects  to  obtain  close-to-ideal  association.  This  critical  flow 
velocity is 
  max crit F a v w Rk H ≈    (19) 
As an example, for wF = 100  m diameter protein spot, this critical flow rate is about 40 
 m/sec,  which  agrees  with  the  simulation  results  in  Fig.  7  which  shows  a  characteristic 
approach to saturation for flow velocities greater than 40  m/sec. 
This discussion provides an estimate of the length scale of the mass transport effect. The 
one-dimensional approximation is valid if an electrokinetically driven flow is used for the 
incubations, for which the flow velocity is a constant across the volume. In an experiment 
with pressure-driven flow, the parabolic velocity profile of the flow affects the size of the 
flow-enhanced edge. Figure 8 shows the simulated average spot height after a 1000 second 
incubation as a function of protein spot diameter, for (a) electrokinetically driven flow and (b) 
pressure driven flow. The kinetic association rate used for the simulations is 1x10
5 M
−1sec
−1, 
and the diffusion coefficient is 40  m
2/sec. For the electrokinetically-driven flow, when the 
spot size is smaller than the length scale of the concentration gradient, no significant mass-
transport limitation occurs. For the pressure driven flow, because the flow velocity close to 
(C) 2010 OSA 1 October 2010 / Vol. 1,  No. 3 / BIOMEDICAL OPTICS EXPRESS  995
#132716 - $15.00 USD Received 2 Aug 2010; revised 16 Sep 2010; accepted 17 Sep 2010; published 20 Sep 2010the surface is always slower, it is more susceptible to mass transport limitations. In either 
case, smaller protein spots lead to less distortion caused by mass-transport effects. 
0
0.5
1
1.5
2
0 20 40 60 80 100 120 140
0 um/sec
0.5 um/sec
5 um/sec
50 um/sec
A
v
e
r
a
g
e
 
P
r
o
t
e
i
n
 
H
e
i
g
h
t
 
(
n
m
)
Protein Spot Diameter ( m)
a)
0
0.5
1
1.5
2
0 20 40 60 80 100 120 140
0 um/sec
0.5 um/sec
5 um/sec
50 um/sec
A
v
e
r
a
g
e
 
P
r
o
t
e
i
n
 
H
e
i
g
h
t
 
(
n
m
)
Protein Spot Diameter ( m)
b)
 
Fig. 8. Average protein height of protein spots with different sizes after 1000 second incubation 
at different flow rates for (a) electrokinetically driven flow and (b) pressure driven flow. 
5.2 Utilizing mass-transport-limited reactions 
One of the challenges for applying antibody microarrays to a complex biological sample such 
as serum or cell lysate is the distinction between specific reactions of low-concentration high-
affinity  target  analytes  and  the  non-specific  binding  of  high-concentration  low-affinity 
background proteins that are present in the biological sample. In the ideal association reaction 
given by Eq. (4), similar assay behaviors occur if the product kaC = constant. On the other 
hand,  as  we  have  shown  in  Fig.  4,  different  association  rates  ka  lead  to  different  height 
responses across a protein spot and to different degrees of distortion from ideal association in 
the time response. Therefore, these deviations provide experimental information that can be 
used  to  separate  low-concentration-high-affinity  from  high-concentration-low-affinity 
reactions. For instance, Fig. 9(a) shows the simulated spot height of different reactions that 
hold the product of ka and C constant at ka[C] = 0.005 sec
−1 for an incubation time of 200 
seconds. From the spatial shape of the response height, high association rate reactions result in 
much larger inhomogeneity. Figure 9(b) shows the average spot height of the binding, with 
higher ka (consequently smaller [C]) leading to more distortion from ideal kinetics and slower 
rates. While it is possible to use kinetic time responses to distinguish specific and non-specific 
reactions, we suggest that it is more sensitive to measure the spatial binding inhomogeneity 
across the protein spot. In the Experimental Results section, Fig. 4 showed an experimental 
demonstration  that  distinguished  specific  from  non-specific  reactions.  The  higher-affinity 
reaction of avidin-biotin produced much larger inhomogeneity than low-affinity non-specific 
binding of BSA against protein A/G. By operating in the mass-transport-limited regime and 
measuring the binding profile, one can obtain more detailed understanding of the reaction 
kinetics. 
(C) 2010 OSA 1 October 2010 / Vol. 1,  No. 3 / BIOMEDICAL OPTICS EXPRESS  996
#132716 - $15.00 USD Received 2 Aug 2010; revised 16 Sep 2010; accepted 17 Sep 2010; published 20 Sep 20100
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 50 100 150
ka = 10
6 M
-1sec
-1
ka = 10
5 M
-1sec
-1
ka = 10
4 M
-1sec
-1
ka = 10
3 M
-1sec
-1
P
r
o
t
e
i
n
 
H
e
i
g
h
t
 
C
h
a
n
g
e
 
(
n
m
)
Position ( m) (y)
a)
0
0.2
0.4
0.6
0.8
1
0 100 200 300 400 500
ka = 10
6 M
-1sec
-1
ka = 10
5 M
-1sec
-1
ka = 10
4 M
-1sec
-1
ka = 10
3 M
-1sec
-1
P
r
o
t
e
i
n
 
H
e
i
g
h
t
 
C
h
a
n
g
e
 
(
n
m
)
Time (sec)
b)
 
Fig. 9. (a) Binding profile within a protein spot and (b) binding kinetics at different kinetic 
association rates for ka[C] = 0.005 sec
−1. High association rate leads to larger inhomogeneity 
which can be easily distinguished from low association rate non-specific binding. 
6. Conclusions 
Mass-transport  limitation  is  one  of  the  key  bottlenecks  to  the  sensitivity  of  solid-support 
antibody microarrays. The common assay format of high-density antibody microspots is prone 
to local analyte depletion adjacent to the protein spots when the mass transport of analyte is 
too  slow.  The  ambient-analyte  assay  condition  dictates  that  the  overall  concentration  of 
capture agent (when averaged over the volume within which analyte is transported to the 
surface) should be much smaller than the equilibrium concentration of analyte. Therefore, to 
limit assay deviations caused by mass transport rates, the local immobilized concentration 
must be small to prevent significant local analyte depletion. This requires either enhancing 
mass transport through faster flow velocity, or reducing the size of the microspot, both of 
which place constraints on the design of experiments. 
As  an  alternative,  in  this  paper  we  have  shown  that  high-resolution  molecular 
interferometric imaging (MI2) can measure spatially inhomogeneous binding profiles under 
mass-transport-limited conditions. The high spatial resolution of MI2 enables us to examine 
the effect of mass transport on an assay in greater detail than has been previously reported. By 
combining  the  experimental  results  of  MI2  with  a  finite-element  simulation  program,  we 
extracted accurate kinetic properties of the reaction, such as the diffusion coefficient of the 
analyte,  as  well  as  distinguishing  among  reactions  with  different  association  rates.  We 
provided guidelines in the form of simple equations (rules of thumb) for designing optimal 
parameters of an assay system, such as spot size and flow rate, to limit the mass transport 
effects. 
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